GlaxoSmithKline is buying Human Genome Sciences for $3.6 billion, giving it full ownership of Benlysta, along with albiglutide and darapladib, after months of M&A intrigue. “We are pleased to have ...
WASHINGTON (CBSNewYork.com/AP) The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in over 50 years, a milestone that medical ...
Please provide your email address to receive an email when new articles are posted on . Uptake of belimumab continues to outpace the use of anifrolumab among clinicians managing patients with systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results